您的位置: 首页 > 农业专利 > 详情页

HER2/NEU CANCER VACCINE
专利权人:
ICON GENETICS GMBH;UNIVERSITY OF SOUTHAMPTON
发明人:
Natalia Savelyeva,Franziska Jarczowski,Romy Kandzia,Anja Nickstadt,Frank Thieme,Victor Klimyuk,Yuri Gleba,Duc Bui-Minh,Freda K. Stevenson,Warayut Chotprakaikiat
申请号:
US14774304
公开号:
US20160015796A1
申请日:
2014.03.11
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Protein conjugate comprising a protein antigen for generating an immune response against the HER2/neu protein and an immunogenic carrier covalently bonded to said protein antigen, wherein said protein antigen(i) has a sequence segment of 300 or more contiguous amino acids of the amino acid sequence of SEQ ID NO: 1; or(ii) has a variant sequence segment of 300 or more amino acid residues, wherein the amino acid sequence of said variant sequence segment has at least 85% sequence identity to a sequence portion from SEQ ID: 1; or(iii) has a variant sequence segment of 300 or more amino acid residues and has from 1 to 10 substitutions, deletions or additions in said variant sequence segment compared to a sequence segment of 300 or more amino acid residues of the amino acid sequence of SEQ ID NO: 1 or 2.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充